D. E. Shaw & Co., Inc. Precigen, Inc. Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Precigen, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,784,886 shares of PGEN stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,784,886

Previous 1,009,447 76.82%

Holding current value

$2.5 Million

Previous $1.35 Million 91.42%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.21 - $1.75 $938,281 - $1.36 Million	775,439 Added 76.82%	1,784,886 $2.59 Million
Q4 2023 Feb 14, 2024	BUY	$0.89 - $1.41 $316,621 - $501,614	355,755 Added 54.42%	1,009,447 $1.35 Million
Q3 2023 Nov 14, 2023	BUY	$1.08 - $1.85 $55,022 - $94,251	50,947 Added 8.45%	653,692 $928,000
Q2 2023 Aug 14, 2023	SELL	$0.96 - $1.4 $150,469 - $219,434	-156,739 Reduced 20.64%	602,745 $693,000
Q1 2023 May 15, 2023	BUY	$0.88 - $2.19 $11,440 - $28,470	13,000 Added 1.74%	759,484 $805,000

Q4 2022 Feb 14, 2023	BUY	$1.27 - $2.26 $126,494 - $225,100	99,602 Added 15.4%	746,484 $1.13 Million
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $211,449 - $418,399	-149,964 Reduced 18.82%	646,882 $1.37 Million
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $82,466 - $181,426	-71,710 Reduced 8.26%	796,846 $1.07 Million
Q1 2022 May 16, 2022	BUY	$1.91 - $3.98 $1.51 Million - $3.14 Million	788,222 Added 981.18%	868,556 $1.83 Million
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $37,820 - $58,927	10,714 Added 15.39%	80,334 $298,000
Q3 2021 Nov 15, 2021	SELL	$4.99 - $6.55 $862,706 - $1.13 Million	-172,887 Reduced 71.29%	69,620 $347,000
Q2 2021 Aug 16, 2021	SELL	$6.24 - $8.22 $3.15 Million - $4.15 Million	-504,305 Reduced 67.53%	242,507 $1.58 Million
Q1 2021 May 17, 2021	BUY	$6.74 - $10.95 $357,368 - $580,590	53,022 Added 7.64%	746,812 $5.15 Million
Q4 2020 Feb 16, 2021	BUY	$3.75 - $10.56 $1.5 Million - $4.24 Million	401,134 Added 137.07%	693,790 $7.08 Million
Q3 2020 Nov 16, 2020	SELL	$3.5 - $6.2 $179,123 - $317,303	-51,178 Reduced 14.88%	292,656 $1.03 Million
Q2 2020 Aug 14, 2020	BUY	$2.16 - $5.46 $468,735 - $1.18 Million	217,007 Added 171.1%	343,834 $1.72 Million
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $185,167 - $911,886	126,827 New	126,827 $431,000

Others Institutions Holding PGEN

# of Institutions

141

Shares Held

145M

Call Options Held

208K

Put Options Held

43.7K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $291M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account